Other researchers [103] reported that, in patients with severe COVID-19 and ARDS, high levels of the monocyte chemoattractant MCP-1 drive recruitment of monocytes from the circulation and lead to a preponderance of hyperinflammatory macrophages in airway fluids and lung tissue. The gene discussed is CCL2; the disease is COVID-19.